Health news
Uyghur detention camps in China’s western Xinjiang province have a shoot-to-kill policy for those who try to escape, according to leaked documents seen by the BBC. The Xinjiang Police Files, a huge cache of data hacked from police computer servers in the region, also include thousands of police photographs of Uyghurs in detention camps. The…
LOS ALTOS, Calif. – November 10, 2022 – (Newswire.com)
InterMed Resourc…
The aesthetic device innovator’s partnership with Advalight builds on the company’s continued vision for global expansion and market development.
LAS VEGAS – November 10, 2022 – (Newswire.com)
Reveal Lasers LLC, a wholly owned subsidiary of Reveal Lasers LTD, is pleased to announce their marketing and distribution agreement with Advalight, global manufacturers of the ADVATx device, the world’s only medical, solid-state laser producing both 589nm and 1319nm wavelengths.
For Advalight, partnering with Reveal Lasers provides a proven and growing distribution team in North America to further launch ADVATx. This aligns with Advalight’s mission to grow the brand globally. With numerous FDA-cleared indications ranging from vascular abnormalities to acne, wrinkle reduction and warts, ADVATx has been adopted as the laser modality of choice for physicians dedicated to offering their patients the safest and most advanced laser solutions available.
Travis Mahan, President of Advalight, stated, “Partnering with Reveal Lasers represents an important milestone in the growth of ADVATx in North America. The leadership team at Reveal has a demonstrated track record of successfully bringing groundbreaking technology like the ADVATx to the aesthetics market, and we are thrilled to pair our best-in-class technology with their world-class sales, marketing and practice support acumen.”
“Reveal Lasers is excited to partner with Advalight to further expand the reach of their ADVATx device in North America,” said Bob Daley, CEO of Reveal Lasers. “ADVATx is a global brand known around the world for its stellar manufacturing and superior clinical outcomes for patients and providers.”
To learn more about Reveal Lasers LLC and ADVATx, visit us.reveallasers.com.
About Reveal Lasers
Reveal Lasers LTD is a global leader in the innovation of minimally invasive cosmetic surgical procedures, medical treatments, and aesthetic solutions for providers and clinics. Born from a group of aesthetic industry veterans boasting over 50 years of collective industry experience, the company’s skills and expertise primarily encompass the development of energy Laser, Radiofrequency (RF), and Intense Pulse Light (IPL). The manufacturer ensures the uncompromising quality of products and the highest return on investment in the industry while committing to complete customer satisfaction by offering its partners a comprehensive support system for product implementation, marketing, and more.
About Advalight
Advalight is the company behind ADVATx and was founded in 2006 as a result of their founder’s Ph.D. studies at the Technical University of Denmark. The company is headquartered in Copenhagen, Denmark, and has a sales and service office in San Diego, CA, USA. ADVATx is available through our network of global distributors.
Contact Information:
Dean Fiacco
VP of Operations
(518)527-2558
Press Release Service
by
Newswire.com
Original Source:
Reveal Lasers Announces Distribution Agreement With Advalight
The Covid-19 Detection Foundation (Dba Virufy) is the newest member of BARDA’S division of research, innovation, and ventures (DRIVe) medical countermeasures portfolio
SAN FRANCISCO – November 10, 2022 – (Newswire.com)
Lessons learned from the COVID-19 pandemic underscore the need for more rapidly scalable, low-cost, and broadly available approaches in responding to public health emergencies. Digital tools like smartphone or web-based applications present opportunities for new classes of medical countermeasures that could complement traditional approaches. Aiming for easy detection of Covid-19, Virufy has created an IA-based app that should make the diagnosis of the disease more inclusive.
Through AI/ML algorithms, smartphone and computer applications can use images and audio captured with the phone or computer’s existing hardware to assess aspects of a person’s health. Health-related image and audio recordings contain much more information than the human eye or ear alone can process, but AI/ML algorithms could be used to process that information, detect differences and patterns among images and sounds, and identify disease signatures. These digital tools could empower individuals with actionable information about their infection status or acute skin condition and symptoms so that they can self-isolate and seek medical care if appropriate.
Virufy is developing an app that uses a few seconds of cough audio, collected through a smartphone or computer microphone, to identify cough patterns indicative of a current COVID-19 infection. Virufy has demonstrated this capability based on an analysis of several thousand samples from international clinical networks and through crowdsourcing. With DRIVe’s support, Virufy will conduct additional clinical studies to refine and test their algorithm. Virufy will also initiate proof-of-concept work on AI algorithms to screen for other respiratory diseases based on cough audio.
VisualDx aims to create an AI/ML algorithm that analyzes user-provided skin lesion images together with a symptom questionnaire on a smartphone app. The algorithm can provide information on the indicated disease and other similarly presenting conditions. If successful, this project would demonstrate the power of AI/ML-based image analysis for easily and rapidly accessible symptom checking for potentially any pox-based virus such as smallpox or monkeypox, and provide a digital health solution that could be modified easily in a future outbreak.
BARDA’s 2022-2026 Strategic Plan emphasizes the importance of preparing for future public health emergencies by collaborating with innovators to develop medical countermeasures that can help save lives. Cutting-edge, digital guidance tools that can pivot and be brought to scale in response to new threats could aid in public health response. These DRIVe projects, if successful, could demonstrate the power of these tools to rapidly respond to other threats such as influenza and smallpox.
These awards have been made under the Easy Broad Agency Announcement (EZ-BAA) area of interest (AOI) #9: Digital Medical Countermeasures.
This project has been funded in part with Federal funds from HHS/ASPR and BARDA, under Contract No. 75A50122C00034.
Contact Information:
Patricia Zylberman
PR Manager
+5511972447743
Press Release Service
by
Newswire.com
BOCA RATON, Fla. – November 10, 2022 – (Newswire.com)
ASP Isotopes Inc. …
Beauty – Trend Magazine originally published at Beauty – Trend Magazine Beauty – Trend Magazine originally published at Beauty – Trend Magazine
Event with BrainBristle Devangana at break from BrainBristle Devangana with a student A letter was written by the young, CEO of BrainBristle questioning global thinkers and media narratives for those diagnosed on the spectrum of autism. With every other child we raise, we think of their careers logically, we think of professions yielding respect, respite,…
Miami luxury condos can be found in every neighborhood and I have been fortunate enough to not only see them all, but to have watched their performance over the years, analyzed and dissected their floor plans and studied their condo docs and financials. So when I say I know these condos, I can tell you […]
The post The Best Miami Luxury Condos for 2022 | My Top 5 Best Miami Condos Explained. first appeared on Miami In News.
Humongous, immense, enormous, gargantuan, massive and huuuge, these are just a couple of adjectives that could be used
Zendaya Reveals Why She Almost Quit Euphoria Euphoria fans were obviously geared up for season 2 of the show in January 2022, but was the star of the show, Zendaya, equally excited? Is it true that Zendaya almost quit Euphoria? And what really made her almost quit the show? Zendaya’s portrayal of Rue in Euphoria […]
